贝勒医学院的研究人员发现了潜在的非侵入性便检测标记物和子宫内膜异位症的治疗代谢物. Researchers at Baylor College of Medicine identified potential non-invasive stool test markers and a therapeutic metabolite for endometriosis.

贝勒医学院的研究人员已经发现一种潜在的非侵入性便检测和一种新型治疗子宫内膜异位症的方法, Researchers at Baylor College of Medicine have identified a potential non-invasive stool test and a novel therapy for endometriosis, a condition affecting nearly 200 million women globally. 他们的研究显示, 患有子宫内膜异位症和没有子宫内膜异位症的女性之间便细菌和代谢物有明显的差异, Their study revealed distinct differences in stool bacteria and metabolites between women with and without endometriosis, suggesting these could serve as diagnostic markers. 值得注意的是,一种叫作4-氢氧丁二醇的代谢物可以防止疾病蔓延,从而推动对其治疗潜力的进一步研究。 Notably, a metabolite called 4-hydroxyindole may prevent disease progression, prompting further research on its therapeutic potential.